Antiobesity therapeutics with complementary dual-agonist activities at glucagon and glucagon-like peptide 1 receptors.
Park BG, Kim GM, Lee HJ, Ryu JH, Kim DH, Seong JY, Kim S, Park ZY, Kim YJ, Lee J, Kim JI.
Park BG, et al. Among authors: kim ji, kim yj, kim dh, kim gm, kim s.
Diabetes Obes Metab. 2022 Jan;24(1):50-60. doi: 10.1111/dom.14546. Epub 2021 Sep 24.
Diabetes Obes Metab. 2022.
PMID: 34491605